Home › Compare › OCTHF vs RYLD

OCTHF vs RYLD: Dividend Comparison 2026

OCTHF yields 71428.57% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCTHF wins by $1.6804617092236922e+25M in total portfolio value
10 years
OCTHF
OCTHF
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full OCTHF calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — OCTHF vs RYLD

📍 OCTHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCTHFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCTHF + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
OCTHF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCTHF
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, OCTHF beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCTHF + RYLD for your $10,000?

OCTHF: 50%RYLD: 50%
100% RYLD50/50100% OCTHF
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCTHF buys
0
RYLD buys
0
No recent congressional trades found for OCTHF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCTHFRYLD
Forward yield71428.57% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.6804617092236922e+25M$44.5K ✓
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00 ✓$2,587.35
Total dividends collected$1.6801590475897682e+25M$18.8K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: OCTHF vs RYLD ($10,000, DRIP)

YearOCTHF PortfolioOCTHF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$7,153,557$7,142,857.14$11,914$1,213.65+$7.14M → OCTHF
2$4,783,059,608$4,775,405,302.31$14,099$1,351.30+$4783.05M → OCTHF
3$2,989,196,089,253$2,984,078,215,471.53$16,580$1,494.55+$2989196.07M → OCTHF
4$1,746,108,740,720,723$1,742,910,300,905,223.00$19,384$1,642.61+$1746108740.70M → OCTHF
5$953,366,906,359,837,700$951,498,570,007,266,600.00$22,535$1,794.70+$953366906359.82M → OCTHF
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$26,063$1,950.00+$486546837026708.50M → OCTHF
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$29,995$2,107.69+$232096820383666624.00M → OCTHF
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$34,361$2,266.99+$103489940016498147328.00M → OCTHF
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$39,194$2,427.12+$4.313365375045453e+22M → OCTHF
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$44,525$2,587.35+$1.6804617092236922e+25M → OCTHF

OCTHF vs RYLD: Complete Analysis 2026

OCTHF — Stock

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Full OCTHF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this OCTHF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCTHF vs SCHDOCTHF vs JEPIOCTHF vs OOCTHF vs KOOCTHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.